Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
from WebMD Health https://ift.tt/37Pjx0C
via IFTTT
Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
Comments
Post a Comment